Advanced standard biological extracts serving as active therapeutic ingredients, manufactured under stringent global validation protocols.
The Egyptian pharmaceutical market is undergoing a historic structural transformation. Supported by the state-led Egypt Vision 2030, the nation is actively seeking to reduce its dependency on imported active pharmaceutical ingredients (APIs) and move up the value chain toward high-tech, bio-based, and natural API alternatives. Historically dependent on synthetic molecule imports, Egyptian pharmaceutical formulation manufacturers in Medicine City (Gypto Pharma), 6th of October City, and Badr City are transitioning toward plant-derived therapeutics, nutraceutical ingredients, and phyto-pharmaceutical compounds.
Natural APIs (Active Pharmaceutical Ingredients derived from botanical sources) represent a key frontier. The Egyptian Drug Authority (EDA) has established streamlined pathways for registering complementary medicine and herbal therapies, recognizing their lower toxicity profile, multi-target therapeutic efficacy, and high consumer acceptance. As a leading global Natural API manufacturer, we provide the raw materials necessary to drive this shift, helping local formulation companies secure stable, high-yield active compounds that comply with European Pharmacopoeia (EP), United States Pharmacopeia (USP), and local EDA guidelines.
As the most populated country in the Middle East and North Africa (MENA) region, Egypt possesses a domestic pharmaceutical market valued at over USD 4.5 billion. However, up to 90% of the active raw materials used in local drug synthesis are imported. This systemic vulnerability, combined with foreign currency fluctuations, has spurred the Egyptian government to prioritize the localization of pharmaceutical raw materials. While local efforts are focused on basic synthesis, high-purity phytochemical extraction remains a highly specialized discipline requiring advanced chromatography, countercurrent extraction, and high-efficiency purification technologies.
The business model in Egypt is pivoting from simple trading of finished dosage forms to the contract manufacturing (tolling) of complex formulations. This has created a massive demand among Egyptian manufacturing groups for reliable OEM/ODM biological API manufacturers. Key therapeutic areas driving the demand for natural APIs in Egypt include metabolic health management (specifically anti-diabetic and lipid-lowering compounds, given the high local prevalence of metabolic conditions), hepatoprotective formulations, cardiovascular therapeutics, and anti-inflammatory dermatology products.
Worldwide, the pharmaceutical industry is witnessing a structural shift toward "Green Chemistry" and plant-based active molecules. This movement is driven by:
China is the global powerhouse for plant extraction, combining raw material cultivation networks with massive industrial scale and high-end scientific research. Chengdu Chenlv Herb Co., Ltd. stands at the forefront of this industrial advantage. Established in 2012, we operate a 2,711 m² state-of-the-art facility utilizing modern countercurrent extraction lines, industrial chromatography columns, and membrane separation technologies.
Our extraction lines process hundreds of tons of botanical materials annually. This scale provides a cost-efficiency and chemical purity profile that cannot be replicated by smaller regional extraction units. Located in Sichuan, China—a region renowned for rich bio-resource diversity—we maintain strict traceability from raw botanical sourcing to the finalized API powder. Every batch is supplied with an exhaustive Certificate of Analysis (CoA), including heavy metal, pesticide residue, and microbial profiles, ensuring seamless importation and registration with the Egyptian Drug Authority.
Standardized botanical active compounds targeted for hepatoprotective, cardiovascular, and immunological therapeutic developments.
Chengdu ChenLv Herb Co.,Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics. Driven by innovation, science, and green production, we represent a trustworthy gateway to premium natural APIs for manufacturers worldwide.
Inquire About Our FacilitiesEstablished In
Choose Chenlv Herb for products that deliver beyond expectations, supporting your biological innovation pipelines.
Developing natural ingredients that meet modern standard requirements for diverse pharmaceutical and nutritional sectors.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have become the core raw materials for natural supplements.
From herbal formulas recorded in ancient texts to modern innovative drugs, plant extracts occupy a prominent position due to clear active mechanisms.
With consumer pursuit of safe skincare, plant extracts serve as favorites in cosmetics due to their mildness, versatility, and bio-compatibility.
Plant extracts show great potential in improving animal immunity, performance, and health, replacing antibiotics in livestock feed.
Chenlv Herb provides comprehensive one-stop contract manufacturing and optimization services.
Determine target molecular weight, botanical source, and purity requirements.
Provide transparent cost proposals aligned with regional regulatory requirements.
Secure product specifications, quality baselines, and delivery milestones.
Produce pilot laboratory batches for target stability and dissolution tests.
Scale extraction and crystallization protocols in our GMP-compliant plant.
Independent analysis including HPLC, GC-MS, and heavy metal testing.
Deliver fully cleared shipments to Cairo, Alexandria, or global hubs.
Our raw material sourcing and extraction procedures are validated by major international compliance bodies.
Natural active molecules find high-value application scenarios in Egypt's specific epidemiological and public health landscapes. Developing local natural alternatives has targeted strategic therapeutic domains:
Egypt has one of the highest metabolic disease prevalence rates globally. Berberine Hydrochloride has emerged as a key clinical target for natural therapeutics. Operating through AMPK pathway activation, Berberine helps regulate insulin sensitivity and cholesterol levels. Integrating high-purity Berberine into local pharmaceutical formulations in Egypt offers clinical-grade metabolic support with low gastrointestinal side effects. Similarly, Apigenin helps modulate glucose pathways while mitigating chronic metabolic inflammation.
Chronic venous insufficiency (CVI) and diabetic microvascular issues are common clinical challenges in urban and rural Egyptian patient groups. Hesperidin Methyl Chalcone, combined with flavonoids like Troxerutin, acts to reduce capillary permeability and improve vascular tone. These compounds are widely utilized by Egyptian drug formulators in topically applied gels and oral capsule formulations for microvascular protection.
The intense UV climate in Egypt calls for robust skincare protection against photo-aging, hyperpigmentation, and solar damage. Traditional synthetic brighteners face strict regulatory scrutiny. Natural alternatives like Tetrahydrocurcumin (a colorless, highly stable metabolite of curcumin) and Luteolin offer excellent anti-oxidant protection. Free of yellow staining, Tetrahydrocurcumin is highly sought after by local Egyptian dermatological brands for formulations targeting hyperpigmentation, skin repair, and post-procedure recovery.
Egypt's aquaculture in the Nile Delta and animal husbandry sectors are shifting away from synthetic growth promoters due to strict export restrictions. Natural APIs like Andrographolide and Naringin provide immune-modulatory, anti-bacterial, and anti-inflammatory properties, promoting gut health and weight gain in poultry and aquaculture setups naturally.
Answering key regulatory, chemical, and logistics questions for importing Natural APIs into Egypt and regional MENA hubs.
Yes. We supply comprehensive technical dossiers (including DMF structures, stability test records, and validation data) to help Egyptian pharmaceutical and nutraceutical manufacturers register formulations with the EDA under the natural and complementary medicine pathway.
We run automated extraction lines monitoring critical parameters (temperature, pressure, and solvent flow) in real-time. Each batch is validated using HPLC, UV, and GC testing, ensuring active marker assays remain consistent across seasons.
Our general MOQ starts at 25kg for standard catalogue products. For customized extraction specs (such as custom mesh sizes or targeted purities), the MOQ is determined based on the pilot run requirements. Please contact our team for specific details.
We package our active botanical powders in food-grade double-layered polyethylene bags inside heavy-duty fiber drums. For moisture-sensitive ingredients, we include desiccant packets and vacuum-seal bags to ensure chemical stability under hot regional storage conditions.
Our manufacturing plant and processes hold valid HALAL and KOSHER certifications alongside our ISO9001 and ISO22000 quality systems, facilitating smooth customs clearance in Middle Eastern and North African ports.
Standardized natural active pharmaceutical ingredients prepared for international shipping, complete with standard CoA and trace documents.
Explore raw material dynamics, extraction innovations, and event notifications from Chengdu Chenlv Herb.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise. As the new production season comes to an end, price fluctuations become a key factor in manufacturing costing.
As a major showcase for China's biological active ingredient sector, the 23rd CPHI China will present a premier platform for exploring botanical extraction advancements.
Join us at the API conference as we display our latest technological milestones in phytochemical active molecules and natural therapeutic compounds.
